ABBV-154

ABBV-154 is an anti-TNF steriod conjugate being investigated to treat rheumatoid arthritis.

Type of Molecule

Biologic

Target

TNF

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Rheumatoid Arthritis (RA) n/a
Phase 1